期刊文献+

清肠灌肠方治疗溃疡性结肠炎临床疗效及对VEGF的影响 被引量:1

Effect of Qingchang Guanchang Fang on Treatment of Ulcerative Colitis and VEGF Expression
下载PDF
导出
摘要 目的:观察"清肠灌肠方"对溃疡性结肠炎(UC)患者的临床疗效及对血管内皮生长因子(VEGF)的影响。方法:将UC患者60例随机分为"清肠灌肠方"治疗(中药组)和柳氮磺胺吡啶治疗(SASP组),各30例。治疗4周后,观察临床症状、结肠镜下黏膜改变以及治疗前后VEGF表达的变化。结果:中药组症状改善和结肠镜下黏膜炎症修复情况均优于SASP组(P<0.05),提高VEGF表达作用优于SASP组(P<0.05)。结论:"清肠灌肠方"治疗UC疗效显著,该方通过提高VEGF表达提高溃疡愈合质量,可能是其促进溃疡愈合的机制之一。 Objective : To observe the effect of Qingchang Guanchang Fang on treatment of ulcerative colitis ( UC and VEGF expression. Methods: 60 cases with UC were randomly divided into TCM group treated by Qingchang Guanchang Fang (30 cases) and SASP group treated by salicylazosulfapyridine (30 cases). After therapy for 4 weeks, the clinical curative effect, variation of mucous membrane by the enteroscopy, and VEGF expression before and after the therapy were observed. Results:The symptom improvement and the restoration of mucous membrane's inflammation in the TCM group were obviously better than those in the SASP group ( P 〈 0.05). VEGF expression in the TCM group was also increased compared with that in the SASP group (P 〈 0.05). Conclusion: Qingchang Guanchang Fang has significant curative effect on treatment of UC. Improvement of VEGF expression and ulcer concrescence quality maybe the mechanicsm of Qingchang Guanchang Fang in acceleration of ulcer concrescence.
作者 朱凌宇 顾贤
出处 《浙江中西医结合杂志》 2008年第6期345-347,共3页 Zhejiang Journal of Integrated Traditional Chinese and Western Medicine
关键词 溃疡性结肠炎 清肠灌肠方 血管内皮生长因子 ulcerative colitis Qingchang Guanchang Fang salicylazosulfapyridine (SASP) VEGF
  • 相关文献

参考文献4

  • 1郑芝田.胃肠病学.第3版.北京:人民卫生出版社,2006.790-792.
  • 2中华医学会消化病分会.对炎性肠病诊断治疗规范的建议[J].中华消化杂志,2001,(1):56-59.
  • 3Truelove SC, Richards WC. Biopsy studies in ulcerative colitis. Br Med J, 1956,2 : 1315-1322
  • 4张伟,王吉耀.溃疡性结肠炎的药物治疗进展[J].胃肠病学和肝病学杂志,2001,10(2):120-124. 被引量:32

二级参考文献43

  • 1[1]Prakash A,Markham A.Oral delayed-release mesalazine:a review of its use in ulcerative colitis and Crohn′s disease.Drugs,1999,57(3):383-408
  • 2[2]Sutherland LR,Roth DE,Beck PL.Alternatives to sulfalazine:a meta-analysis of 5-ASA in the treatment of ulcerative colitis.Inflammatory Bowel Dis,1997,34:65-78
  • 3[3]Sutherland L,Roth D,Beck P et al.The use of oral 5-aminosalicylic acid in the induction of remission in ulcerative colitis.In:The Cochrane Library(database on disk and CD-ROM).Oxford:The Cochrane Collaboration.Update Software,1998(4)
  • 4[4]Sutherland L,Roth D,Beck P et al.The use of oral 5-aminosalicylic acid in the induction of maintenance of remission in ulcerative colitis.In:The Cochrane Library(database on disk and CD-RON).Oxford:The Cochrane Collaboration.Update Software,1998,(4)
  • 5[5]Kruis W,Brandes JW,Schreiber S,et al.Olsalaxine versus mesalazine in the treatment of mild to moderate ulcerative colitis.Aliment Pharmacol Ther,1998,12(8):7607-15
  • 6[6]Stoa-Birketvedt G,Florholmen J.The systemic load and efficient delivery of active 5-aminosalicylic acid in patients with ulcerative colitis on treatment with olsalazine or mesalazine.Aliment Pharmacol Ther,1999,13(3):357-61
  • 7[7]Prakash A,Spencer CM.Balsalazide.Drugs,1998,56(1):83-9
  • 8[8]Green JR,Gibson JA,Kerr GD,et al.Maintenance of remission of ulcerative colitis:a comparison between balsalazide 3g daily and mesalamine 1.2g daily over 12 month.ABACUS Investigator Group.Aliment Pharmacol Ther,1998,12(12):1207-16
  • 9[9]Gionchetti P,Rizzello F,Venturi A,et al.Comparison of oral with rectal mesalazine in the treatment of ulcerative proctitis.Dis Colon Rectum,1998,41(1):93-7
  • 10[10]Safdi M,DeMicco M,Sninsky C,et al.A double-blind comparison of oral versus rectal mesalamine versus combination therapy in the treatment of distal ulcerative colitis.Am J Gastroenterol,1997,92(10):1867-71

共引文献32

同被引文献26

引证文献1

二级引证文献8

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部